Patents by Inventor Rob Tressler

Rob Tressler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10723805
    Abstract: Provided herein are antibodies specific for CLL-1.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: July 28, 2020
    Assignee: Cellerant Therapeutics, Inc.
    Inventors: Ping Jiang, Holger Karsunky, Rob Tressler
  • Publication number: 20180273633
    Abstract: Provided herein are antibodies specific for CLL-1.
    Type: Application
    Filed: December 22, 2017
    Publication date: September 27, 2018
    Inventors: Ping Jiang, Holger Karsunky, Rob Tressler
  • Patent number: 9850314
    Abstract: Provided herein are antibodies specific for CLL-1.
    Type: Grant
    Filed: September 14, 2015
    Date of Patent: December 26, 2017
    Assignee: Cellerant Therapeutics, Inc.
    Inventors: Ping Jiang, Holger Karsunky, Rob Tressler
  • Publication number: 20150376290
    Abstract: Provided herein are antibodies specific for CLL-1.
    Type: Application
    Filed: September 14, 2015
    Publication date: December 31, 2015
    Inventors: Ping Jiang, Holger Karsunky, Rob Tressler
  • Patent number: 9163090
    Abstract: Provided herein are antibodies specific for CLL-1.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: October 20, 2015
    Assignee: Cellerant Therapeutics, Inc.
    Inventors: Ping Jiang, Holger Karsunky, Rob Tressler
  • Publication number: 20130295118
    Abstract: Provided herein are antibodies specific for CLL-1.
    Type: Application
    Filed: March 11, 2013
    Publication date: November 7, 2013
    Applicant: Cellerant Therapeutics, Inc.
    Inventors: Ping Jiang, Holger Karsunky, Rob Tressler